Ketryx Secures $39M Series B to Enhance AI Compliance in Life Sciences

September 04, 2025
Ketryx has raised $39 million in a Series B funding round led by Transformation Capital to advance its AI-powered compliance platform for life sciences. The funding will support the company's efforts to automate regulatory workflows and accelerate product release cycles.

Ketryx has raised $39 million in a Series B funding round led by Transformation Capital, announced in a press release. The funding aims to scale Ketryx's AI-native compliance platform, which is designed to help life sciences companies accelerate product innovation while maintaining safety and compliance.

The platform automates validation, traceability, and regulatory workflows, including FDA and EU MDR-ready documentation, across the product development lifecycle. This allows teams to release safer products faster, with customers reporting up to a 90% reduction in documentation time and over 10x faster release cycles.

Ketryx's compliance infrastructure is already trusted by three of the top five global medtech companies and several Fortune 500 organizations. With the new funding, the company plans to continue its global expansion, accelerate its product roadmap, and increase hiring in both Boston and Austria.

We hope you enjoyed this article.

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Trend report

Cybersecurity Trends Report 2025

Netwrix

The Cybersecurity Trends Report 2025 by Netwrix Research Lab provides insights into how organizations are adapting their cybersecurity strategies amidst growing AI adoption. The report, based on a survey of 2,150 IT professionals from 121 countries, highlights key trends such as the increase in hybrid IT environments, AI-driven security challenges, and the rising costs of security incidents.

Read more